DM0000: The mark consists of square design to the left of the wording "EffPha" in blue. The color blue also appears in the upper right corner portion of a square design and has a vertical gradient going from a darker blue to a milder blue, then to a light blue. The color orange appears in the leftmost vertical stripe of the square design. The color green appears in the lower right portion of the square design. A circular figure is cut out of the center of the square design, which is transparent in color. Two vertical parallel lines cut through the square design, also transparent in color. The wording "Efficient Pharma Management Corp." appears below the square design and the wording "EffPha", in gray. The color white merely indicates background and is not part of the mark.
CC0000: The color(s) blue, orange, green, gray is/are claimed as a feature of the mark.
D10000: "PHARMA MANAGEMENT CORP."
GS0421: Bacteriological consultation and research; Biochemical research and development; Biological research; Chemical analysis; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Cosmetic research consultation; Cosmetics research; Cosmetics research for others; Development of pharmaceutical preparations and medicines; Drug discovery services; Information on the subject of scientific research in the field of biochemistry and biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development consultation; Product development for others; Product research; Product research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development for new products for others; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research in the field of chemistry; Research on the subject of pharmaceuticals; Scientific research and development
Case File Event Statements
9/5/2023 - a year ago
29 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA